BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32894076)

  • 1. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
    Guad RM; Taylor-Robinson AW; Wu YS; Gan SH; Zaharan NL; Basu RC; Liew CSL; Wan Md Adnan WAH
    BMC Nephrol; 2020 Sep; 21(1):388. PubMed ID: 32894076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
    Reddy YN; Abraham G; Sundaram V; Reddy PP; Mathew M; Nagarajan P; Mehra N; Ramachandran A; Ali AA; Reddy YN
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1113-20. PubMed ID: 26586047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
    Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
    Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation.
    Nagaraja P; Ravindran V; Morris-Stiff G; Baboolal K
    Transpl Int; 2013 Mar; 26(3):273-80. PubMed ID: 23230898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary kidney transplant recipients.
    Gaynor JJ; Ciancio G; Guerra G; Sageshima J; Hanson L; Roth D; Goldstein MJ; Chen L; Kupin W; Mattiazzi A; Tueros L; Flores S; Barba LJ; Lopez A; Rivas J; Ruiz P; Vianna R; Burke GW
    Clin Transplant; 2015 Apr; 29(4):301-10. PubMed ID: 25581205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
    Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T
    Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.
    Luan FL; Steffick DE; Ojo AO
    Transplantation; 2011 Feb; 91(3):334-41. PubMed ID: 21242885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia.
    Sinangil A; Celik V; Barlas S; Sakaci T; Koc Y; Basturk T; Akin EB; Ecder T
    Prog Transplant; 2016 Mar; 26(1):55-61. PubMed ID: 27136250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up.
    Tillmann FP; Schmitz M; Rump LC; Quack I
    Int Urol Nephrol; 2018 Apr; 50(4):771-777. PubMed ID: 29197933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year incidence of post-transplant Diabetes Mellitus in renal transplant patients.
    Habibnia F; Oliaei F; Shirafkan H; Abbasi Firoozjah M; Rezaei Roshan M; Akbari R
    Diab Vasc Dis Res; 2022; 19(6):14791641221137352. PubMed ID: 36471497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus.
    Kurzawski M; Dziewanowski K; Łapczuk J; Wajda A; Droździk M
    Eur J Clin Pharmacol; 2012 Dec; 68(12):1587-94. PubMed ID: 22569928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study.
    Rathi M; Rajkumar V; Rao N; Sharma A; Kumar S; Ramachandran R; Kumar V; Kohli HS; Gupta KL; Sakhuja V
    Transplant Proc; 2015 May; 47(4):1158-61. PubMed ID: 26036543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation.
    Parvizi Z; Azarpira N; Kohan L; Darai M; Kazemi K; Parvizi MM
    Mol Biol Rep; 2014 Sep; 41(9):6063-9. PubMed ID: 24996284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation.
    Bayés B; Lauzurica R; Granada ML; Serra A; Bonet J; Fontseré N; Salinas I; Romero R
    Transplantation; 2004 Jul; 78(1):26-30. PubMed ID: 15257035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial nitric oxide synthase gene intron 4 polymorphism predicts new onset diabetes mellitus after transplantation in kidney allograft recipients treated with cyclosporin A.
    Ergün I; Keven K; Sengül S; Karabulut HG; Kurultak I; Soypacaci Z; Erbay B
    Int Urol Nephrol; 2011 Jun; 43(2):543-8. PubMed ID: 20559724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients.
    Burroughs TE; Swindle JP; Salvalaggio PR; Lentine KL; Takemoto SK; Bunnapradist S; Brennan DC; Schnitzler MA
    Transplantation; 2009 Aug; 88(3):367-73. PubMed ID: 19667939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
    Borda B; Lengyel C; Várkonyi T; Kemény E; Ottlakán A; Kubik A; Keresztes C; Lázár G
    Acta Physiol Hung; 2014 Sep; 101(3):388-94. PubMed ID: 25183511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients.
    Tavira B; Coto E; Díaz-Corte C; Ortega F; Arias M; Torres A; Díaz JM; Selgas R; López-Larrea C; Campistol JM; Ruiz-Ortega M; Alvarez V;
    Clin Transplant; 2011; 25(3):E284-91. PubMed ID: 21355884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium.
    Jacobson PA; Schladt D; Israni A; Oetting WS; Lin YC; Leduc R; Guan W; Lamba V; Matas AJ;
    Transplantation; 2012 Mar; 93(6):624-31. PubMed ID: 22334041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.